Ovid Therapeutics
OVID
OVID
82 hedge funds and large institutions have $14.5M invested in Ovid Therapeutics in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
–
Holders Change %
0%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
10
Increased
20
Reduced
28
Closed
9
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$3K
Top Buyers
| 1 |
SCM
Sio Capital Management
New York
|
+$384K |
| 2 |
Renaissance Technologies
New York
|
+$286K |
| 3 |
AAA
Affinity Asset Advisors
New York
|
+$208K |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$153K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$112K |
Top Sellers
| 1 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$2.66M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$881K |
| 3 |
MAP
Madison Avenue Partners
New York
|
-$392K |
| 4 |
MCM
Monimus Capital Management
Woodbridge,
New Jersey
|
-$129K |
| 5 |
JPMorgan Chase & Co
New York
|
-$65.4K |
